title: Malignant tumours after renal transplantation.
abstract: In 1243 patients after renal transplantation, 39 malignant tumours were detected in 37 patients. The average latency period between transplantation and tumour disease was 72 months. Tumours included 8 malignant lymphomas, 7 dermatomas and 24 visceral tumours. The patients who developed a tumour had received fewer blood transfusions before transplantation than a tumour-free control group of 60 patients with renal transplants. Rejection crises occurred in a significantly smaller number of tumour patients compared with the control group.
authors.affiliation: Department of Urology, Charité Hospital, Medical School, Humboldt University Berlin.
authors.forename: D
authors.initials: D
authors.lastname: Fahlenkamp
authors.forename: P
authors.initials: P
authors.lastname: Reinke
authors.forename: S
authors.initials: S
authors.lastname: Kirchner
authors.forename: D
authors.initials: D
authors.lastname: Schnorr
authors.forename: A
authors.initials: A
authors.lastname: Lindeke
authors.forename: S A
authors.initials: SA
authors.lastname: Loening
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D011183:Postoperative Complications; D011239:Prednisolone / Q000008:administration & dosage; D012306:Risk
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone